It has no known interaction with semaglutide (which is administered by injection)
J Biol Chem 273(32):2037820382 Reuter SE, Evans AM (2012) Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects
I dont think many people (like 95% on here who opine about this ) who have never really personally felt the rath of spending a big chunk of their net worth on healthcare $$$, realize how incredibly expensive the GLP-1s are for employers
This is a high-risk population, and historically weve had limited data to guide treatment decisions, said Amy Sheer, MD, associate professor of medicine and director of the Obesity Medicine Fellowship program at the University of Florida
Its nanoformulations, however, may introduce new safety considerations